Sub Markets

Property Sectors

Topics

Boston & New England CRE News In Your Inbox.

Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.

Boston & New England  + Boston  + Industrial  | 
Life science real estate vacancies and leasing in the Bay Area are beginning to normalize to pre-pandemic levels, according to research from Transwestern

Boston Life Sciences Vacancies: Highest in 15 Years

Vacancies are rising in metro Boston, especially in the life sciences sector, with a 17% vacancy rate, the highest in over 15 years. This includes record amounts of direct (5.7 million square feet) and sublease (2.8 million square feet) space, according to Colliers Boston 23Q4 Life Sciences report.

In 2021, only about 500,000 square feet were available, highlighting the recent shift. Despite over 8 million square feet being delivered in 2023, with 63% leased, 37% of new space is empty, and 6% is available for sublease, contributing to rising vacancies. With over 10 million square feet still underway, vacancies are expected to continue rising. However, net absorption in 2023 was healthy, with pent-up demand being absorbed.

Local firms received over $7.5 billion in venture capital last year, indicating leasing potential. Flagship Pioneering also seeks to raise $3 billion in a new VC fund.

Read More News Stories About: Colliers
Connect

Inside The Story

About Emily Fu

Emily Fu is Content Director of Connect Commercial Real Estate, where she covers the east coast markets, including New York, Boston & New England, and DC & Mid-Atlantic markets. She produces daily news stories as well as longer-form content, ranging from Q&As to thought-leadership pieces. She also writes feature stories for Connect Money. With previous stints at Reuters, Seeking Alpha, and Commercial Observer, Emily has covered the finance side of the commercial real estate industry, technology, media, telecom (TMT), and fashion. She attended the Columbia Graduate School of Journalism and currently resides in Manhattan.

  • ◦Development
New call-to-action